Aspira Women’s Health Establishes a New Clinical Advisory Board
October 23, 2023 08:00 ET
|
Aspira Women's Health Inc.
AUSTIN, Texas, Oct. 23, 2023 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira” or “the Company”) (Nasdaq: AWH), a bio-analytical company focused on the development and commercialization of...
Aspira Women’s Health to Present at the BioVenture Nexus Conference
September 29, 2023 08:00 ET
|
Aspira Women's Health Inc.
AUSTIN, Texas, Sept. 29, 2023 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira” or “the Company”) (Nasdaq: AWH), a bio-analytical company focused on the development and commercialization of...
Aspira Women’s Health Regains Nasdaq Compliance
September 13, 2023 08:00 ET
|
Aspira Women's Health Inc.
AUSTIN, Texas, Sept. 13, 2023 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira” or “the Company”) (Nasdaq: AWH), a bio-analytical company focused on the development and commercialization of...
Aspira Women’s Health Announces Dr. Jody Berry as New Chief Scientific Officer
September 11, 2023 08:00 ET
|
Aspira Women's Health Inc.
AUSTIN, Texas, Sept. 11, 2023 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira” or “the Company”) (Nasdaq: AWH), a bio-analytical company focused on the development and commercialization of...
Aspira Women’s Health Signs Exclusive Sample Procurement Agreement with The University of Oxford
August 31, 2023 08:00 ET
|
Aspira Women's Health Inc.
Samples to be used in validating the Company’s EndoCheckSM test in development for the diagnosis of endometriosis AUSTIN, Texas, Aug. 31, 2023 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc....
Aspira Women’s Health to Present at the H.C. Wainwright 25th Annual Global Investment Conference
August 29, 2023 08:00 ET
|
Aspira Women's Health Inc.
AUSTIN, Texas, Aug. 29, 2023 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira” or “the Company”) (Nasdaq: AWH), a bio-analytical company focused on the development of women’s health...
Aspira Women’s Health Announces Michelle Snider as Senior Vice President, Commercial Strategy and Operations
August 28, 2023 08:00 ET
|
Aspira Women's Health Inc.
AUSTIN, Texas, Aug. 28, 2023 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc.(“Aspira” or “the Company”) (Nasdaq: AWH), a bio-analytical company focused on the development of women’s health diagnostic...
Aspira Women’s Health® Reports Second Quarter 2023 Financial Results
August 14, 2023 16:01 ET
|
Aspira Women's Health Inc.
Continued growth trend with second quarter revenue of $2.5 million, an increase of 23% over the second quarter of 2022. OvaSuiteSM volume of 6,289 units, an increase of 16% year-over-year ...
Aspira Women’s Health Announces Transition of its Chief Scientific Officer/Chief Operating Officer
August 09, 2023 16:05 ET
|
Aspira Women's Health Inc.
AUSTIN, Texas, Aug. 09, 2023 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira” or “the Company”) (Nasdaq: AWH), a bio-analytical based women’s health company focused on the development of...
Aspira Women’s Health to Announce Second Quarter Earnings Results and Host a Conference Call on Monday, August 14, 2023
July 31, 2023 08:00 ET
|
Aspira Women's Health Inc.
AUSTIN, Texas, July 31, 2023 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira”), a bio-analytical based women’s health company focused on the development of gynecologic disease diagnostic...